EveryONE Medicines is pioneering a scalable, global framework to design, develop, and manufacture individualized medicines for children with life-threatening neurodegenerative diseases. We are building an integrated, end-to-end system that leverages connections to a network of diagnostic firms, treatment centers, and a standardized AI-driven ASO drug design and development process—one that can be scaled to treat thousands of children and sustained through new regulatory pathways and accelerated reimbursement. By employing advanced algorithms and proprietary ASO design, we aim to correct unique genetic variants causing these diseases with individualized therapies.